ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Excerpts Presented From Pepper Hearing

July 20, 1979

Committee Approves NDA For Tamoxifen

January 21, 1977

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998

Symposium Addresses FCC issues

February 21, 1986

Funding Opportunities

October 4, 2002

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003